300869.SZ · 康泰医学
China A-shares · RS rating 30 · As of 2026-10-14
| Price | 10.55 CNY |
|---|---|
| 1-day change | -3.2% |
| RS rating (overall / 1M / 3M / 12M) | 30 / 48 / 57 / 17 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 24 / 17 / 12 |
| Industry group (rank) | Medical-Products (64) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | +25.2% |
| Distance from 52-week high | +40.1% |
| Market cap (USD) | $668.2M |